United States Antimony Corporation
NYSE:UAMYIndustrial Materials
+$0.10 today
- Market cap
- $376.31M
- Beta
- 0.31
- P/E (TTM)
- -67.9
- EPS (TTM)
- -$0.11
Volume 6.45M
Average 11.89M
UAMY Sales of Investments
Cash received from selling or redeeming investments.
United States Antimony CorporationNYSE: UAMY
Sales of Investments · Q1 FY2026 · quarter ended Mar 2026
Sales of investments outflow grows to $0
Q1 FY2026 sales of investments was $0, compared with $0 a year earlier. Trailing-twelve-month sales of investments was $0.
Context
- Sales of investments amounted to 0.0% of revenue in FY2025, down 0.5 pp from a year earlier.
- Sales of investments increased in 0 of the last 3 fiscal years.
- FY2025 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly sales of investments holds near $0 or moves back toward the trailing-twelve-month quarterly average of $0.
Sources:Cash FlowText generated from reported figures; not investment advice.
Sales of Investments history
USD · from the cash flow
- Latest · FY2025
- 0 USD
- Year-over-year change
- -100.0%
| Period | Period end | Sales of Investments | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 0 | -100.0% |
| FY2024 | 2024-12-31 | 72.9K | -61.0% |
| FY2023 | 2023-12-31 | 186.96K | -98.8% |
| FY2022 | 2022-12-31 | 16.13M | +7578.8% |
| FY2021 | 2021-12-31 | 210K | — |
Sales of Investments vs competitors
How UAMY compares with its peers on the latest reported figures
- Peers report in different currencies, so sales of investments is compared through growth and share of revenue rather than absolute size.
- Sales of investments amounts to 0.0% of revenue for UAMY, versus a peer median of 0.0%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
LARLithium Argentina AG | LTM Mar 2026 | $77.39M USD | — | — | — |
| LTM Mar 2026 | $14.12M USD | -32.7% | +36.9% | 0.4% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Jun 2025 | $0 USD | — | — | 0.0% | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| LTM Feb 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | — | |
| LTM Mar 2026 | CA$0 CAD | — | — | — | |
| LTM Mar 2026 | $0 USD | — | — | 0.0% | |
| Peer median (excluding UAMY) | — | -32.7% | +36.9% | 0.0% | |
Competitors are the stored peer set for UAMY. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | (60.47K) | 428.66K | (6.35M) | (1.73M) | (4.34M) |
| Depreciation & Amortization | 880.88K | 909.22K | 959.45K | 1.09M | 1.17M |
| Deferred Income Tax | 0 | 0 | 687.53K | 0 | 0 |
| Stock-Based Compensation | 47.5K | 61.46K | 0 | 568.59K | 7.08M |
| Change in Working Capital | (2.82M) | (2.06M) | (2.61M) | 2.1M | (12.02M) |
| Accounts Receivables | (686.93K) | (607.45K) | (80.57K) | (270.26K) | (3.1M) |
| Inventory | (405.21K) | (596.79K) | (2.08M) | 74.74K | (12.2M) |
| Accounts Payables | (491.12K) | (756.95K) | (171.87K) | 1.09M | 3.4M |
| Other Working Capital | (1.24M) | (100.28K) | (274.79K) | 1.21M | (126.29K) |
| Other Non-Cash Items | (475.63K) | 412.86K | 2.56M | 195.58K | (1.58M) |
| Operating Cash Flow | (2.43M) | (249.28K) | (4.75M) | 2.22M | (9.69M) |
| Capital Expenditures | (648.13K) | (1.73M) | (1.53M) | (430.6K) | (27.81M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 | 0 |
| Purchases of Investments | (215K) | (16.18M) | 0 | 0 | (57.11M) |
| Sales of Investments | 210K | 16.13M | 186.96K | 72.9K | 0 |
| Other Investing Activities | 0 | 0 | 0 | 315.63K | (2.49M) |
| Investing Cash Flow | (653.13K) | (1.79M) | (1.34M) | (42.07K) | (87.4M) |
| Debt Repayment | (186.43K) | (64.75K) | (283.56K) | (103.49K) | (132.25K) |
| Common Stock Issued | 23.34M | 0 | 0 | 2.76M | 110.06M |
| Common Stock Repurchased | 0 | (202.98K) | 0 | 0 | (449.48K) |
| Dividends Paid | 0 | 0 | (787.73K) | 0 | 0 |
| Other Financing Activities | 626.8K | 0 | 0 | 1.48M | 0 |
| Financing Cash Flow | 23.78M | (267.73K) | (1.07M) | 4.14M | 109.48M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 | 0 |
| Net Change in Cash | 20.7M | (2.3M) | (7.16M) | 6.32M | 12.39M |
| Free Cash Flow | (3.08M) | (1.98M) | (6.28M) | 1.79M | (37.5M) |
United States Antimony Corporation
NYSE:UAMY
Intrinsic Alpha fair value
Locked
Current Price
$2.52
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.